Opinion|Videos|March 21, 2025
Integrating Bispecific Antibodies in Community Oncology: Benefits and Considerations
Experts discuss the benefits of implementing and operationalizing bispecifics in the community oncology setting.
Advertisement
Episodes in this series
Video content above is prompted by the following:
What are the benefits of implementing/operationalizing bispecifics in the community oncology setting?
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
Bringing CAR T-Cell Therapy Into Community Cancer Centers
2
The True Cost of Running a Community CAR T-Cell Program
3
Texas Hospitals Lose $27 Million a Day in Medicaid Funding Dispute
4
FDA Approves First Disease-Modifying Treatment for AxD
5